Status:
COMPLETED
Growth Hormone and Chromosome 18q- and Abnormal Growth
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
South Texas Veterans Health Care System
Genentech, Inc.
Conditions:
Loss of Chromosome 18q
Growth Hormone Deficiency
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE3
Brief Summary
We, the investigators at the University of Texas Health Science Center at San Antonio, want to learn if height and IQ (intelligence quotient) scores are improved by growth hormone (GH) treatment in ch...
Detailed Description
HYPOTHESIS: Our hypothesis with reference to children with 18q deletions who have abnormal growth are: * growth hormone will improve growth; and * growth hormone will improve performance IQ (pIQ). ...
Eligibility Criteria
Inclusion
- Diagnosis of chromosome 18 deletion (cytogenetics report)
- Children with abnormal growth but who are not classically growth hormone deficient
Exclusion
- Children previously on growth hormone therapy
Key Trial Info
Start Date :
February 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00134420
Start Date
February 1 2001
End Date
June 1 2005
Last Update
August 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229-3900